zacks.com · 2 jul

Why Regeneron (REGN) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

fool.com · 1 jul

Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57%

It might pull it off, provided several things fall right in place.

reuters.com · 29 jun

FDA selects Lilly, Regeneron for program to speed up review of new manufacturing facilities, CNBC reports

The U.S. ​Food and ‌Drug Administration has ​selected Eli ​Lilly and Regeneron , ⁠among ​seven companies, ​for a pilot program ​to ​accelerate reviews of ‌new ⁠domestic pharmaceutical manufacturing facilities, CNBC ​reported ​on ⁠Monday citing ​an ​FDA ⁠spokesperson.

cnbc.com · 29 jun

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the FDA's PreCheck pilot program. The FDA PreCheck program is designed to accelerate regulatory review of new pharmaceutical manufacturing facilities.

fool.com · 27 jun

This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested

Parabilis saw its shares rise by more than SpaceX's shares did after its IPO. That doesn't mean it's guaranteed to succeed.

feeds.newsfilecorp.com · 26 jun

From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.com, a leading investment platform for retail investors

globenewswire.com · 25 jun

Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast

TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2026 financial and operating results on Thursday, July 30, 2026, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.

fool.com · 25 jun

Is AbbVie a Buy After Its Purchase of Apogee?

The pharmaceutical company gains a prospective blockbuster with the deal, but is it worth $10.9 billion?